Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance
October 28, 2025 6:51 AM EDTLabcorp (NYSE: LH) reported Q3 EPS of $4.18, $0.05 better than the analyst estimate of $4.13. Revenue for the quarter came in at $3.56 billion versus the consensus estimate of $3.56 billion.
GUIDANCE:
Labcorp sees FY2025 EPS of $16.15-$16.50, versus the consensus of $16.30.
For earnings history and earnings-related data on Labcorp (LH) click here.
... More